SARS

Raffles Medical Group upgraded to 'buy' on improved risk-reward: Maybank - THE EDGE SINGAPORE

Broker's Calls

Raffles Medical Group upgraded to 'buy' on improved risk-reward: Maybank

Following a share price correction, Maybank Kim Eng Research analyst Lai Gene Lih has upgraded Raffles Medical Group to “buy”.

Global review

Residential property prices supported by QE, low interest rates, shrinking supply, says RHB

The Singapore residential property market is probably a lot more resilient during Cov-id-19 than it was either during the Asian Financial Crisis (AFC), SARS or the Global Financial Crisis (GFC). Despite the “circuit breaker” measu

Investing ideas

STI components now vs 2003 shows volatility has yet to run its course

SINGAPORE (Feb 10): As of of Feb 5, 28 persons in Singapore have succumbed to the novel coro­navirus which originated from Wu­han city in China. And the epidemic is expected to impact the city state’s economy and employ­ment rate, says the government

Global Economy

Tourism businesses worldwide brace for a hit worse than SARS

China’s increased affluence and consumption since SARS have made many international cities, luxury brands and retail industry groups more reliant than ever on Chinese travelers.

This new anti-viral drug could beat Ebola, SARS, H5N1 Avian Bird Flu, and more

SINGAPORE (Feb 28): Singapore eDevelopment (SeD) announced Wednesday that its biomedical subsidiary, Global BioLife Inc., has completed the Zaire Ebola virus research portion for the study of a new anti-viral drug called LB2.

Broker's Calls

Which stocks risk getting bitten by Zika?

SINGAPORE (Sept 2): Unsurprisingly, the recent Zika outbreak in Singapore is expected to send shockwaves across local markets, especially with the rapid acceleration of virus cases. The number of infections within the republic stands at 151 as of Thursday
×